Email Updates

Search form

You are here

AVAC in the News

  • After decades of intense effort, an effective vaccine against HIV is not on the horizon — and, some say, may never be possible. So some AIDS researchers are going passive. As in passive immunization.

    April 18, 2018
    Antibody Related Research
    NPR
  • HIV researcher Robert Redfield will lead the Centers for Disease Control and Prevention (CDC)…“I hope [that as CDC director] he would be able to maintain the commitment to evidence that has been the hallmark of his career to date,” says Mitchell Warren.

    March 21, 2018
    General
    Nature
  • Robert Redfield's decades of scientific work is "peerless," said Health and Human Services Secretary Alex Azar in a statement released Wednesday. But others point to his checkered past, including allegations of scientific misconduct.

    March 21, 2018
    General
    Buzzfeed
  • AVAC Executive Director Mitchell Warren argues for the use of voluntary medical male circumcision as one of the most powerful and cost-effective HIV prevention tools available.

    March 19, 2018
    BBC World Servce
  • Precisely because of the overwhelming success in recent years of oral PrEP -- which various large studies have found to prevent HIV by anywhere between 90 to 100 percent -- that the future of the douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

    March 1, 2018
    The Body
  • Advocates working to end the AIDS epidemic fear they may lose ground under the Trump administration after coming within reach of ending the disease’s siege in the US and abroad.

    February 27, 2018
    The Hill
  • Several vaccines and drugs for preventing the spread of HIV are showing signs of success in clinical trials, three decades after scientists began the search. But some researchers fear that progress will stall without a coordinated strategy to ensure that the most promising therapies to prevent infection win support from policymakers and reach the people who need them.

    February 27, 2018
    Nature
  • The Initiative for Multi-Purpose Technologies (IMPT) has published these remarks on the role of end-user research in the development of multi-purpose technologies (MPTs). Leading experts, including AVAC's Anabel Gomez, reflect on considerations for applying this research effectively while framing a few central questions it can address.

    December 21, 2017
    IMPT
  • Six short videos describe how a Kenyan nonprofit organization tackles one of Africa’s toughest missions: helping young women protect themselves against HIV.

    December 15, 2017
    The New York Times
  • A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future. When analyzing federal funding by the US government for HIV both home and abroad since the first AIDS cases were identified in 1981, “you notice a very dramatic, steep rise at different points, and generally a rise over time,” said Jen Kates, vice president, director of global health and HIV policy, Kaiser Family Foundation.

    December 11, 2017
    General
    AJMC

Pages